Albuminuria and poor glycemic control predict mortality in NIDDM

Publisher Website
Google Scholar
Abstract
The impact of microalbuminuria and macroalbuminuria on mortality was evaluated prospectively in 328 Caucasian patients with non-insulin-dependent diabetes mellitus (NIDDM) followed for 5 years. One hundred ninety-one (109 men and 82 women) patients with normoalbuminuria (albumin excretion rate [AER] <30 mg/24 h), 86 (50 men and 36 women) patients with microalbuminuria (AER 30–299 mg/24 h), and 51 (43 men and 8 women) patients with macroalbuminuria (AER ≥300 mg/24 h) <66 years old at entry were followed from 1987 until death or until 1 January 1993. Mean age at entry was 54 (SD 9) years. In January 1993, 8% of patients with normoalbuminuria, 20% of patients with microalbuminuria, and 35% of patients with macroalbuminuria had died (predominantly from cardiovascular disease) ( P <0.01 [normoalbuminuria versus micro- and macroalbuminuria] and P <0.05 [microalbuminuria versus macroalbuminuria]). Cox multiple regression analysis revealed significant predictors of all-cause mortality to be preexisting coronary heart disease (relative risk [95% confidence interval]), 2.9 (1.6–5.1); log10AER (factor 10), 1.9 (1.4–2.6); HbA1c level (%), 1.2 (1.0–1.4); and age (years), 1.08 (1.03–1.13). Significant predictors of cardiovascular mortality included preexisting coronary heart disease, 6.1 (2.8–13.5); macroalbuminuria, 2.5 (1.1–5.8); HbA1c level (%), 1.3 (1.1–1.6); and systolic blood pressure (10 mmHg), 1.2 (1.0–1.4). Univariate Cox survival analysis in the normoalbuminuric group revealed that AER above the median of 8 mg/24 h was associated with an increased all-cause mortality risk of 2.7 (0.93–7.69) ( P = 0.07). We conclude that abnormally elevated urinary albumin excretion and poor glycemic control indicate a substantially increased allcause, mainly cardiovascular, mortality risk in NIDDM patients.